Get your 2022 networking started! Against the backdrop of a global pandemic, 2021 was the year of the vaccine and the year of innovation and optimism. Clearly we have not yet reached our destination, but in many ways Medicon Valley and Medicon Valley Alliance did, however, come out of 2021 stronger. To part with the […]

– an international outlook and regional challenges  Hologic Global Women’s Health Index is a unique survey based on 120 000+ interviews representing 2.5 billion women and girls. Using the index as a starting point, we discuss possible ways forward for Swedish and Danish women’s health – with a focus on cancer prevention. How can we mitigate the impact […]

Getting Ahead of Tumor Evolution – ​Changing the Premises in the War Against Cancer Join distinguished speakers from the UK, USA, Germany, Switzerland, Canada, and Norway as they discuss recent progress in the understanding of tumor evolution and emerging diagnostic and treatment options for solid and hematological cancers. Cancer Crosslinks 2022 will be A Digital/Hybird […]

Health Capital Helsinki is arranging an online event together with BioInnovation Institute (BII), based in Denmark, on Thursday 27 January, 11:00-15:00 (EET). Receiving funding and even finding all the various funding opportunities are far from easy. And what do the funding institutions look for when they explore which early-stage life-science projects to fund? These questions […]

HALOS and Medicon Valley Alliance invite you to join us for a half-day symposium on how to benefit from using the large-scale research infrastructures such as MAX IV and ESS, and how the unique resources available in the Öresund-Hamburg area could be utilised in life science. During the symposium we will focus on using or […]

One of the major recent trends in drug development in oncology, particularly with highly targeted therapy and immunotherapy, is a great concern with efficacy assessment in early phases of development. This was not frequent before the era of precision medicine. As a result, phase 1 trials now routinely have efficacy endpoints and even sample-size justification […]

Medicon Valley Alliance, together with Bacthera, have the pleasure to invite you to the Medicon Valley Alliance Microbiome Network meeting on 9th of February, 2022 in Copenhagen. Live biotherapeutic products (LBPs) are living microorganisms administered therapeutically and the human microbiome is an increasingly important avenue of health research. Today, we know that the microbiome plays […]

The pharmaceutical pipeline is gaining momentum, led by many first-time launchers. But the reality is companies spend >$200MM over three years leading up to launch, and 66% of drugs still don’t meet launch expectations. This looming risk, echoed by general industry pressures, leaves developers and investors alike looking for more advanced commercialisation options that effectively […]

Medicon Valley Alliance together with member company Miltenyi Biotec have the pleasure to invite you to the 12th meeting of the Medicon Valley Alliance Oncology Network on the 16th of March, 2022. Immuno-oncology is sometimes referred to as the fifth pillar of cancer treatment, alongside surgery, radiotherapy, chemotherapy and precision therapy. The activation and utilization […]

Medicon Valley Microbiome Pitch Day is a unique event to showcase research projects and startups in the microbiome field looking for collaboration or investment — with regional, national or international partners. It will be in-person at the Malmömässan event centre in Malmö and feature a number of exciting presentations across five hours with plenty of […]

Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science and created a unique place to do business. Most attendees express their delight in the informal atmosphere, combined with an […]

BioTrinity 2022: Catalysing Growth in the Life Sciences Industry BioTrinity is an established, must-attend London conference, that catalyses growth and supports in-person re-engagement across the life sciences industry. The event is attended by an ever-evolving audience of early stage and emerging life sciences R&D Companies, investors, large pharma, and other valued partners throughout the life […]

Registration is open for the18th Annual Anglonordic Life Science Conference with 10% MVA member discount Anglonordic is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other. With an established format of panel discussions, parallel technology and biotech investment rooms, plus 1:1 meetings, this conference provides exceptional […]

For the last 7 years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science strategy, investment, partnering and deal making. In 2022 the LSX World Congress will be returning as a physical event, with an additional virtual partnering week. It will include everything everyone […]